COVID-19 vaccination in people with multiple sclerosis, real-life experience

BACKGROUND: Vaccination against the severe acute respiratory syndrome coronavirus type-2 (SARS-CoV-2) virus is recommended in multiple sclerosis (MS) to reduce the risk of complications from Coronavirus disease 2019 (COVID-19) infection. These vaccines were not investigated in people with MS (PWMS)....

Descripción completa

Detalles Bibliográficos
Autores principales: Alroughani, Raed, Al-Hashel, Jasem, Abokalawa, Fathi, AlMojel, Malak, Farouk Ahmed, Samar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2022
Materias:
Full Length Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9293951/
https://www.ncbi.nlm.nih.gov/pubmed/35961255
http://dx.doi.org/10.1016/j.clineuro.2022.107374

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9293951/
https://www.ncbi.nlm.nih.gov/pubmed/35961255
http://dx.doi.org/10.1016/j.clineuro.2022.107374

Ejemplares similares